Health Care Policy

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 17034 Experts worldwide ranked by ideXlab platform

Herbert C Schulberg - One of the best experts on this subject based on the ideXlab platform.

  • treating major depression in primary Care practice an update of the agency for Health Care Policy and research practice guidelines
    Archives of General Psychiatry, 1998
    Co-Authors: Herbert C Schulberg, Wayne Katon, Gregory E Simon, John A Rush
    Abstract:

    The Depression Guideline Panel of the Agency for Health Care Policy and Research in 1993 published recommendations for treating major depression in primary Care practice that were often based on studies of tertiary Care psychiatric patients. We reviewed reports of randomized controlled trials in primary Care settings published between 1992 and 1998. This evidence indicates that both antidepressant pharmacotherapy and time-limited depression-targeted psychotherapies are efficacious when transferred from psychiatric to primary Care settings. In most cases, the choice between these treatments should depend on patient preference. Studies to date suggest that improving treatment of depression in primary Care requires properly organized treatment programs, regular patient follow-up, monitoring of treatment adherence, and a prominent role for the mental Health specialist as educator, consultant, and clinician for the more severely ill. Future research should focus on how guidelines are best implemented in routine practice, since conventional dissemination strategies have little impact.

  • clinical practice guidelines for managing major depression in primary Care practice implications for psychologists u s public Health service agency for Health Care Policy and research
    American Psychologist, 1994
    Co-Authors: Herbert C Schulberg, A.j. Rush
    Abstract:

    : Clinical practice guidelines are being developed by professional and governmental bodies to improve the quality of Health Care. The guidelines developed by the U.S. Public Health Service Agency for Health Care Policy and Research seek to improve the primary Care physician's ability to diagnose and treat major depression. Clinical, educational, and research implications for psychologists are considered in light of how the recommended guidelines potentially will influence the nature and quality of Care provided for mood disorders by generalist physicians.

Kenneth M Grundfast - One of the best experts on this subject based on the ideXlab platform.

  • management of otitis media and the new agency for Health Care Policy and research guideline
    Archives of Otolaryngology-head & Neck Surgery, 1994
    Co-Authors: Kenneth M Grundfast
    Abstract:

    In these times of increasing dominance of managed Care and diminishing autonomy for practitioners of medicine, any government pronouncement can be viewed as yet another of many annoyances. For otolaryngologists who yearn for the days when there were not so many intermediaries involved in patient Care, the newly issued Clinical Practice Guideline, Otitis Media with Effusion in Young Children 1 (see reference 2 for highlights) may seem more of an ominous threat than anything remotely beneficial. However, given the inexorable changes that are occurring, the Agency for Health Care Policy and Research (AHCPR) otitis media guideline is probably going to be more helpful than harmful.

A.j. Rush - One of the best experts on this subject based on the ideXlab platform.

John A Rush - One of the best experts on this subject based on the ideXlab platform.

  • treating major depression in primary Care practice an update of the agency for Health Care Policy and research practice guidelines
    Archives of General Psychiatry, 1998
    Co-Authors: Herbert C Schulberg, Wayne Katon, Gregory E Simon, John A Rush
    Abstract:

    The Depression Guideline Panel of the Agency for Health Care Policy and Research in 1993 published recommendations for treating major depression in primary Care practice that were often based on studies of tertiary Care psychiatric patients. We reviewed reports of randomized controlled trials in primary Care settings published between 1992 and 1998. This evidence indicates that both antidepressant pharmacotherapy and time-limited depression-targeted psychotherapies are efficacious when transferred from psychiatric to primary Care settings. In most cases, the choice between these treatments should depend on patient preference. Studies to date suggest that improving treatment of depression in primary Care requires properly organized treatment programs, regular patient follow-up, monitoring of treatment adherence, and a prominent role for the mental Health specialist as educator, consultant, and clinician for the more severely ill. Future research should focus on how guidelines are best implemented in routine practice, since conventional dissemination strategies have little impact.

Michael C Fiore - One of the best experts on this subject based on the ideXlab platform.

  • overview of the agency for Health Care Policy and research guideline
    Tobacco Control, 1998
    Co-Authors: Michael C Fiore
    Abstract:

    I am honoured to be a part of this panel. Our goal is to provide you with a perspective that is both realistic and positive. That perspective is based around the unique opportunity that managed Care organisations (MCOs) have before them. Managed Care organisations have an opportunity to help their enrollees quit smoking—an opportunity not only to save lives, but also to decrease the extraordinary morbidity that results from tobacco addiction. Finally, MCOs have an opportunity to do all of this in a cost-effective manner. The speakers on the panel will first outline the findings of the Agency for Health Care Policy and Research (AHCPR) clinical practice guideline on smoking cessation,1 and then offer insights about the challenges of disseminating such a set of recommendations. They will describe two real world experiences. We will hear that of a managed Care organisation with a wealth of experience and a track record showing how effective systematic tobacco intervention programmes can be implemented. We will also hear about the experience of a managed Care organisation that is initiating a new programme to address tobacco addiction among enrollees. I believe it would be unrealistic to propose that every managed Care organisation agree to the immediate, universal provision of smoking cessation services for every enrollee. There are some clear barriers to implementing such a programme. To help address them, I should like to highlight some of those barriers. First, there are some important “bottom line” issues. A balance must be struck between the short term costs of providing smoking cessation services and the long-term economic benefits to MCOs that are expected to result from the decreased use of HealthCare resources by smokers who quit successfully. Unfortunately, it is not always clear just how extensive those cost benefits will be or when they can be …

  • the agency for Health Care Policy and research smoking cessation clinical practice guideline findings and implications for psychologists
    American Psychologist, 1998
    Co-Authors: David W Wetter, Michael C Fiore, Ellen R Gritz, Harry A Lando, Maxine L Stitzer, Victor Hasselblad, Timothy B Baker
    Abstract:

    : Smoking is the leading cause of preventable morbidity and mortality in the United States, and the Health benefits of quitting smoking are substantial. Nevertheless, over 25% of American adults (48 million individuals) continue to smoke, and the vast majority of quit attempts are unsuccessful. The Agency for Health Care Policy and Research recently addressed the smoking problem by conducting a 2-year research project that was published as the Smoking Cessation Clinical Practice Guideline (Fiore et al., 1996). This article reviews methods, analyses, and results from the Guideline project, and highlights major Guideline recommendations. Guideline findings and recommendations are discussed with respect to their implications for psychology.

  • the agency for Health Care Policy and research smoking cessation clinical practice guideline
    JAMA, 1996
    Co-Authors: Michael C Fiore, David W Wetter, Ellen R Gritz, Victor Hasselblad, William C Bailey, Glen Bennett, Stuart J Cohen, Sally Faith Dorfman, Michael G Goldstein, Jack E Henningfield
    Abstract:

    Objective. —To summarize theSmoking Cessation Clinical Practice Guidelinethat provides recommendations for 3 groups of professionals: primary Care clinicians, smoking cessation specialists, and Health Care administrators, insurers, and purchasers. Participants. —An independent panel of scientists, clinicians, consumers, and methodologists selected by the US Agency for Health Care Policy and Research. Evidence. —English-language, peer-reviewed literature published between 1975 and 1994 that addresses the assessment and treatment of tobacco dependence, nicotine addiction, and clinical practice. Consensus Process. —Four panel meetings were held over 2 years to evaluate meta-analytic and other results, to synthesize the results, and to develop recommendations. TheGuidelinewas repeatedly reviewed and revised. Conclusions. —The panel recommendations address 3 audiences. Major recommendations for primary Care clinicians are to use officewide systems to identify smokers, treat every smoker with a cessation or motivational intervention, offer nicotine replacement except in special circumstances, and schedule follow-up contact to occur after cessation. Major recommendations to smoking cessation specialists are to use multiple individual or group counseling sessions lasting at least 20 minutes each with sessions spanning multiple weeks, offer nicotine replacement, and provide problem-solving and social support counseling. Major recommendations for Health Care administrators, insurers, and purchasers are that tobacco-user identification systems be used in all clinics and that smoking cessation treatment be supported through staff education and training, dedicated staff, changes in hospital policies, and the provision of reimbursement for tobaccodependence treatment. (JAMA. 1996;275:1270-1280)